Pharmaceutical and Life Sciences Deals Insights Quarterly

August 2014
  • Print-friendly version
Pharmaceutical and Life Sciences Deals Insights Quarterly

At a glance

As anticipated in our Q1 report, M&A activity surged in the second quarter of 2014 with 62 deals announced representing almost $170 billion of total value. Turkey’s healthcare industry is poised for significant growth as a result of government initiatives and increasing urbanization. Additionally, its geographic location is an ideal hub for companies seeking to expand in the region. Insights from PwC’s 2014 Integration Survey highlighting key focus areas for executives to achieve M&A integration success.

Further reading:

US Pharmaceuticals and Life Sciences Deals Insights Quarterly Q1 2014

US Pharmaceuticals and Life Sciences Deals Insights Quarterly Q4 2013

US Pharmaceuticals and Life Sciences Deals Insights Quarterly Q3 2013

US Pharmaceuticals and Life Sciences Deals Insights Quarterly Q2 2013